Am J Prev Med

BackgroundSkin cancer, the most common cancer in the U.S., is a major public health problem. The incidence of nonmelanoma and melanoma skin cancer is increasing; however, little is known about the economic burden of treatment.PurposeTo examine trends in the treated prevalence and treatment costs of nonmelanoma and melanoma skin cancers.MethodsThis study used data on adults from the 2002\u20132011 Medical Expenditure Panel Survey full-year consolidated files and information from corresponding medical conditions and medical event files to estimate the treated prevalence and treatment cost of nonmelanoma skin cancer, melanoma skin cancer, and all other cancer sites. Analyses were conducted in January 2014.ResultsThe average annual number of adults treated for skin cancer increased from 3.4 million in 2002\u20132006 to 4.9 million in 2007\u20132011 (p